A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC whose tumor PD-L1 status is considered negative (ROSETTA-Breast)

Principal Investigator

Dr Rene Roux

Contact us

Email: latephaseoncology@ouh.nhs.uk

IRAS number

1012205